DK1693456T3 - Fremgangsmåde til identificering af modulatorer af en G-protein-koblet receptor - Google Patents

Fremgangsmåde til identificering af modulatorer af en G-protein-koblet receptor

Info

Publication number
DK1693456T3
DK1693456T3 DK04818967.4T DK04818967T DK1693456T3 DK 1693456 T3 DK1693456 T3 DK 1693456T3 DK 04818967 T DK04818967 T DK 04818967T DK 1693456 T3 DK1693456 T3 DK 1693456T3
Authority
DK
Denmark
Prior art keywords
protein
dna
coupled receptor
function
identifying
Prior art date
Application number
DK04818967.4T
Other languages
English (en)
Inventor
Osamu Ohara
Takahiro Nagase
Michio Ohishi
Daisuke Okajima
Hiroshi Yokota
Original Assignee
Daiichi Sankyo Co Ltd
Kazusa Dna Res Inst Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd, Kazusa Dna Res Inst Foundation filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of DK1693456T3 publication Critical patent/DK1693456T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
DK04818967.4T 2003-11-19 2004-11-19 Fremgangsmåde til identificering af modulatorer af en G-protein-koblet receptor DK1693456T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2003389624 2003-11-19
JP2004130371 2004-04-26
JP2004304780 2004-10-19
PCT/JP2004/017239 WO2005049833A1 (ja) 2003-11-19 2004-11-19 G蛋白質共役型受容体をコードする遺伝子およびその遺伝子産物

Publications (1)

Publication Number Publication Date
DK1693456T3 true DK1693456T3 (da) 2011-03-21

Family

ID=34623571

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04818967.4T DK1693456T3 (da) 2003-11-19 2004-11-19 Fremgangsmåde til identificering af modulatorer af en G-protein-koblet receptor

Country Status (6)

Country Link
EP (1) EP1693456B1 (da)
JP (1) JP4638354B2 (da)
AT (1) ATE496130T1 (da)
DE (1) DE602004031148D1 (da)
DK (1) DK1693456T3 (da)
WO (1) WO2005049833A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527937B2 (en) 2003-11-19 2009-05-05 Daiichi Sankyo Company, Limited Assay employing a g-protein coupled receptor that is activated by CCK-8S
AU2006241710B2 (en) * 2005-05-02 2011-04-14 Daiichi Sankyo Company, Limited Method for identification of compound having antidepressant effect
EP2085484A4 (en) * 2006-11-02 2010-01-13 Daiichi Sankyo Co Ltd METHOD FOR IDENTIFYING A CONNECTION WITH EFFECTIVE ANXIETY
JP4691571B2 (ja) 2008-03-04 2011-06-01 株式会社マルハニチロ食品 摂食調節剤
JP2010235492A (ja) * 2009-03-31 2010-10-21 Sekisui Chem Co Ltd シャペロニン−目的タンパク質複合体及びその製造方法
CN102460150B (zh) 2009-04-20 2015-05-20 新加坡科技研究局 囊泡系统及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4001976B2 (ja) * 1997-05-23 2007-10-31 オンコセラピー・サイエンス株式会社 ヒトbai遺伝子及びその利用
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
JP2003284573A (ja) * 2001-06-18 2003-10-07 National Institute Of Advanced Industrial & Technology グアノシン三リン酸結合タンパク質共役型の受容体
US20030143668A1 (en) * 2001-06-18 2003-07-31 National Institute Of Advanced Industrial Guanosine triphosphate-binding protein coupled receptors

Also Published As

Publication number Publication date
DE602004031148D1 (de) 2011-03-03
JPWO2005049833A1 (ja) 2007-06-07
ATE496130T1 (de) 2011-02-15
JP4638354B2 (ja) 2011-02-23
EP1693456B1 (en) 2011-01-19
EP1693456A4 (en) 2007-07-11
WO2005049833A1 (ja) 2005-06-02
EP1693456A1 (en) 2006-08-23

Similar Documents

Publication Publication Date Title
BR9912437A (pt) ácidos nucléicos codificando um receptor ligado à proteìna g envolvido na transdução sensória
NO2010021I1 (no) Denosumab
EP1589106A4 (en) ADIPONEKTIN RECEPTOR AND GENERATING ENCODER
WO2004033631A8 (en) Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
BR9912545A (pt) ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial
RU2004125585A (ru) Новые флуоресцирующие белки aequorea coerulscens и способы их применения
DK2020604T3 (da) Ligand for den G-proteinkoblede receptor FPRL2
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
IL138593A (en) Glial factor receptor ??3 (gfr??3) polypeptide, nucleic acid encoding the same, process for preparation thereof, vectors, host cells, antibodies, chimeric molecules and use of such gfr??3
DK1693456T3 (da) Fremgangsmåde til identificering af modulatorer af en G-protein-koblet receptor
CA2525286A1 (en) Materials and methods relating to g-protein coupled receptor oligomers
WO2002102839A3 (en) Novel g-protein coupled receptors and dna sequences thereof
DE60219645D1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
Arfin et al. Proteins and their novel applications
WO2003088910A3 (en) Methods of assaying for cell cycle modulators
WO2003014731A3 (en) The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
JP2010516232A5 (da)
WO2003057827A3 (en) Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes
WO2004074446A3 (en) Parkin interacting polypeptides and methods of use
ATE445159T1 (de) Neues screening-verfahren
DE60026569D1 (de) Zusammensetzungen auf der basis von gfr-alpha-4 und deren anwendungen
Zoranić et al. Hydrophobic moments of voltage sensors in cation channels
RU2005118079A (ru) Флуоресцирующие белки и хромопротеины из видов, не относящихся к aequorea hydrozoa, и способы их получения
GB0520568D0 (en) Receptor
RU2004125291A (ru) Киназа pim-3 в качестве мишени для сахарного диабета типа 2